TrialThe Journal of clinical psychiatry

Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone.

Thomas J Spencer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.